Long-circulating PEGylated manganese ferrite nanoparticles for MRI-based molecular imaging

Area of Science:

• Nanotechnology
• Biomedical Engineering
• Materials Science

Background:

• Conventional MRI contrast agents have limitations in sensitivity and specificity for early disease detection.
• Nanotechnology offers a path to develop advanced contrast agents with improved magnetic and biological properties.
• Molecular imaging requires contrast agents with high specificity, sensitivity, long circulation times, and low toxicity.

Purpose of the Study:

• To develop a facile, robust, and cost-effective method for synthesizing dual T1 and T2 MRI contrast agents.
• To create manganese ferrite nanoparticles (MNPs) with polyethylene glycol (PEG) shells for enhanced stability and circulation.
• To evaluate the magnetic properties and relaxivity of PEGylated MNPs for molecular imaging applications.

Main Methods:

• Synthesized dual T1 and T2 MRI contrast agents using a ligand-exchange method.
• Created manganese ferrite nanoparticles (MNPs) with sizes ranging from 6 to 14 nm.
• Coated MNPs with a 3 kDa polyethylene glycol (PEG) shell to improve stability and circulation time.

Main Results:

• PEGylated MNPs exhibited excellent stability in aqueous media with high crystallinity and magnetization.
• 6 nm PEGylated MNPs showed a low r2/r1 ratio (4.9 at 1.5 T), acting as dual T1/T2 agents at low fields.
• 14 nm PEGylated MNPs demonstrated excellent T2 contrast properties at high fields (r2 = 335.6 mM(-1) s(-1)).
• The PEG shell minimized cytotoxicity and enabled long blood circulation times.

Conclusions:

• PEGylated MNPs are promising dual MRI contrast agents for molecular imaging.
• Their tunable relaxivity based on size and magnetic field makes them versatile for different imaging scenarios.
• The combination of biocompatibility, efficacy, and long circulation time supports their potential clinical translation.